Skadden is representing Merck KGaA in connection with its definitive agreement to acquire all outstanding shares of common stock of the Millipore Corporation for approximately US$7.2 billion. Merck KGaA is a global pharmaceutical and chemical company and Millipore is a leading Life Science company based in Massachusetts. The transaction, announced February 28, was approved by the boards of directors of both companies.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates